v3.25.2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2025
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS
Equity Investment in Privately-Held Eye Care Company
In April 2024, the Company participated in an equity funding round of an early clinical-stage private eye care company. Pursuant to the terms of a Preferred Stock Purchase Agreement, the Company purchased $3.0 million of preferred stock. Drs. Azamian (the Company's CEO and Chair of the Board) and Link (a member of the Company's Board of Directors) are board members of this private company. The Company also owns a small minority of this private company.